Omada Health, Inc.
OMDA
$12.61
$0.040.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 53.24% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 53.24% | -- | -- | -- | |
| Cost of Revenue | 33.39% | -- | -- | -- | |
| Gross Profit | 66.16% | -- | -- | -- | |
| SG&A Expenses | 28.59% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 27.51% | -- | -- | -- | |
| Operating Income | 72.58% | -- | -- | -- | |
| Income Before Tax | 72.89% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 72.89% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 72.89% | -- | -- | -- | |
| EBIT | 72.58% | -- | -- | -- | |
| EBITDA | 83.32% | -- | -- | -- | |
| EPS Basic | 77.98% | -- | -- | -- | |
| Normalized Basic EPS | 78.58% | -- | -- | -- | |
| EPS Diluted | 77.85% | -- | -- | -- | |
| Normalized Diluted EPS | 78.44% | -- | -- | -- | |
| Average Basic Shares Outstanding | 372.53% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 391.55% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |